Nomura Asset Management Co. Ltd. lessened its stake in Molina Healthcare, Inc (NYSE:MOH – Free Report) by 88.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,313 shares of the company’s stock after selling 17,597 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Molina Healthcare were worth $401,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the stock. AQR Capital Management LLC lifted its holdings in shares of Molina Healthcare by 217.0% in the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after buying an additional 2,008,458 shares during the period. Victory Capital Management Inc. lifted its holdings in shares of Molina Healthcare by 344.3% in the 3rd quarter. Victory Capital Management Inc. now owns 963,526 shares of the company’s stock valued at $184,380,000 after buying an additional 746,639 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Molina Healthcare by 31.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 938,677 shares of the company’s stock valued at $179,632,000 after buying an additional 222,346 shares during the period. Norges Bank acquired a new position in shares of Molina Healthcare in the 4th quarter valued at about $109,766,000. Finally, UBS Group AG lifted its holdings in shares of Molina Healthcare by 320.7% in the 3rd quarter. UBS Group AG now owns 603,934 shares of the company’s stock valued at $115,569,000 after buying an additional 460,372 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.
Insider Activity at Molina Healthcare
In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares in the company, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is currently owned by insiders.
Molina Healthcare Stock Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The company had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. During the same period in the previous year, the business earned $6.08 EPS. Molina Healthcare’s quarterly revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Sell-side analysts anticipate that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
MOH has been the subject of a number of analyst reports. TD Cowen reduced their price target on Molina Healthcare from $175.00 to $144.00 and set a “hold” rating for the company in a report on Monday, February 9th. Mizuho reduced their price target on Molina Healthcare from $220.00 to $180.00 and set an “outperform” rating for the company in a report on Thursday, March 12th. Cantor Fitzgerald upped their price target on Molina Healthcare from $144.00 to $209.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Barclays upped their price target on Molina Healthcare from $161.00 to $199.00 and gave the stock an “underweight” rating in a report on Tuesday, May 26th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Molina Healthcare in a report on Friday, March 13th. Three research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $179.93.
Check Out Our Latest Analysis on Molina Healthcare
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Featured Articles
- Five stocks we like better than Molina Healthcare
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
